AbstractObjectivesThe purpose of study was to report the clinical improvement of late complications of COVID-19 patient complaining of dyspnea treated with Korean medicine pulmonary rehabilitation.
MethodsTo assess the treatment outcomes, we used the modified medical research council scale (mMRC), 6-minute walk distance (6MWD), peak expiratory flow rate (PEFR), St. George respiratory questionnaire (SGRQ).
참고문헌1. WHO. Who director-general’s opening remarks at the media briefing on covid-19-11 march 2020 [internet]. Geneva: World health organization;2020. [cited 2020 mar 11]. Available from: https://www.Who.Int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefingon-covid-19---11-march-2020
2. SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, Barzegary A, et al. 2021; Late complications of covid-19; a systematic review of current evidence. Archives of academic emergency medicine. 9:1.
3. Kim D-s, Chu H, Min BK, Moon Y, Park S, Kim K, et al. 2020; Telemedicine center of korean medicine for treating patients with covid-19: A retrospective analysis. Integrative medicine research. 9:3. 100492
![]() ![]() ![]() 4. Lee S, Park J, Lee Y-j, Kim S-h, Lee J. 2021; A case report of taeeumin with post covid-19 syndrome. Journal of Sasang Constitutional Medicine. 33:4. 32–42.
5. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. 1959; Significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. British medical journal. 2:5147. 257
![]() ![]() ![]() 6. Puhan MA, Mador M, Held U, Goldstein R, Guyatt G, Schünemann H. 2008; Interpretation of treatment changes in 6-minute walk distance in patients with copd. European Respiratory Journal. 32:3. 637–643.
![]() 7. Gibson PG. 2002; Outpatient monitoring of asthma. Current Opinion in Allergy and Clinical Immunology. 2:3. 161–166.
![]() ![]() 8. Jones P, Quirk F, Baveystock C. 1991; The st george’s respiratory questionnaire. Respiratory medicine. 85:25–31. discussion 33.
9. Moreno-Pérez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jiménez J, et al. 2021; Post-acute covid-19 syndrome. Incidence and risk factors: A mediterranean cohort study. Journal of Infection. 82:3. 378–383.
![]() 10. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. 2021; Post-acute covid-19 syndrome. Nature medicine. 27:4. 601–615.
![]() ![]() ![]() 11. Carfì A, Bernabei R, Landi F. 2020; Persistent symptoms in patients after acute covid-19. Jama. 324:6. 603–605.
![]() ![]() ![]() 12. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. 2020; Post-discharge persistent symptoms and health-related quality of life after hospitalization for covid-19. Journal of Infection. 81:6. e4–e6.
![]() 13. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. 2021; Postdischarge symptoms and rehabilitation needs in survivors of covid-19 infection: A cross-sectional evaluation. Journal of medical virology. 93:2. 1013–1022.
![]() ![]() 14. Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. 2021; Sixty-day outcomes among patients hospitalized with covid-19. Annals of Internal Medicine. 174:4. 576–578.
![]() ![]() 15. Lee K, Jeong S, Jeong M, Choi Y, Song M, Jang I. 2021; Review on herbal medicine treatment for late complications of covid-19 patients. The Journal of Internal Korean Medicine. 42:1. 53–66.
![]() 16. Lee SW, Park JJ, Lyu YR, Lee EJ, Kim SY, Kang W, et al. 2022; The effect of lung-conduction exercise in chronic obstructive pulmonary disease: Randomized, assessor-blind, multicenter pilot trial. Medicine. 101:3.
![]() |
|